ADHD and secondary ADHD criteria fail to identify many at-risk survivors of pediatric ALL and brain tumor

Pediatric Blood and Cancer

Volumn 57, Issue 1, 2011, Pages 110-118

  Kahalley, Lisa S ^a   Conklin, Heather M ^b   Tyc, Vida L ^b   Wilson, Stephanie J ^b   Hinds, Pamela S ^c,d   Wu, Shengjie ^b   Xiong, Xiaoping ^b   Hudson, Melissa M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

ADHD; Attention; Cancer; Children; Cognitive assessment; Hyperactivity; Oncology

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN TUMOR; CHILD; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SECONDARY ATTENTION DEFICIT DISORDER; SELF REPORT; SURVIVAL RATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; UNITED STATES;

EID: 79955723287     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22998     Document Type: Article

References (53)

1. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000; 15: 603-630.
2. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51: 99-104.
3. Ris MD, Noll RB. Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critique. J Clin Exp Neuropsychol 1994; 16: 21-42.
4. Fossen A, Abrahamsen TG, Storm-Mathisen I. Psychological outcome in children treated for brain tumor. Pediatr Hematol Oncol 1998; 15: 479-488.
5. Holmquist LA, Scott J. Treatment, age, and time-related predictors of behavioral outcome in pediatric brain tumor survivors. J Clin Psychol Med Settings 2002; 9: 315-321.
6. Langer T, Martus P, Ottensmeier H, et al. CNS late-effects after ALL therapy in childhood. Part III: Neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 2002; 38: 320-328.
7. Lockwood KA, Bell TS, Colegrove RW. Long-term effects of cranial radiation therapy on attention functioning in survivors of childhood leukemia. J Pediatr Psychol 1999; 24: 55-66.
8. Rodgers J, Horrocks J, Britton PG, et al. Attentional ability among survivors of leukaemia. Arch Dis Child 1999; 80: 318-323.
9. Troy L, McFarland K, Littman-Power S, et al. Cisplatin-based therapy: A neurological and neuropsychological review. Psychooncology 2000; 9: 29-39.
10. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005; 72: 245-253.
11. Anderson V, Godber T, Smibert E, et al. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: An analysis of risk factors. Pediatr Rehabil 1997; 1: 63-76.
12. Reddick WE, White HA, Glass JO, et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 2003; 97: 2512-2519.
13. Butler RW, Mulhern RK. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol 2005; 30: 65-78.
14. Krull KR, Brouwers P, Jain N, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 2008; 152: 101-105.
15. Patel SK, Lai-Yates JJ, Anderson JW, et al. Attention dysfunction and parent reporting in children with brain tumors. Pediatr Blood Cancer 2007; 49: 970-974.
16. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: A randomized, double-blind, cross-over trial. J Pediatr Psychol 2007; 32: 1127-1139.
17. Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004; 22: 4795-4803.
18. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001; 19: 1802-1808.
19. Conklin HM, Helton S, Ashford J, et al. Predicting methylphenidate response in long-term survivors of childhood cancer: A randomized, double-blind, placebo-controlled, crossover trial. J Pediatr Psychol 2010; 35: 144-155.
20. American Psychiatric, Association. Diagnostic and statistical manual of mental disorders, 4th edition, (text revision). Washington, DC: American Psychiatric Association; 2000.
21. Gerring JP, Brady KD, Chen A, et al. Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Acad Child Adolesc Psychiatry 1998; 37: 647-654.
22. Max JE, Lansing AE, Koele SL, et al. Attention deficit hyperactivity disorder in children and adolescents following traumatic brain injury. Dev Neuropsychol 2004; 25: 159-177.
23. Levin H, Hanten G, Max J, et al. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children. J Dev Behav Pediatr 2007; 28: 108-118.
24. American, Academy of Pediatrics. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000; 105: 1158-1170.
25. McClellan JM, Werry JS. Introduction - research psychiatric diagnostic interviews for children and adolescents. J Am Acad Child Adolesc Psychiatry 2000; 39: 19-27.
26. Pineda DA, Palacio LG, Puerta IC, et al. Environmental influences that affect attention deficit/hyperactivity disorder: Study of a genetic isolate. Eur Child Adolesc Psychiatry 2007; 16: 337-346.
27. Kaplan S, Heiligenstein J, West S, et al. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder. J Atten Disord 2004; 8: 45-52.
28. Mackie S, Shaw P, Lenroot R, et al. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiatry 2007; 164: 647-655.
29. Mostofsky SH, Cooper KL, Kates WR, et al. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2002; 52: 785-794.
30. Herskovits EH, Megalooikonomou V, Davatzikos C, et al. Is the spatial distribution of brain lesions associated with closed-head injury predictive of subsequent development of attention-deficit/hyperactivity disorder? Analysis with brain-image database. Radiology 1999; 213: 389-394.
31. Gerring J, Brady K, Chen A, et al. Neuroimaging variables related to development of Secondary Attention Deficit Hyperactivity Disorder after closed head injury in children and adolescents. Brain Inj 2000; 14: 205-218.
32. Welner Z, Reich W, Herjanic B, et al. Reliability, validity, and parent-child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA). J Am Acad Child Adolesc Psychiatry 1987; 26: 649-653.
33. Rogers R. Handbook of diagnositc and structured interviewing. New York: Guilford Press; 2001.
34. Reeves CB, Palmer SL, Reddick WE, et al. Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 2006; 31: 272-280.
35. Reddick WE, Shan ZY, Glass JO, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006; 106: 941-949.
36. Mulhern RK, White HA, Glass JO, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004; 10: 180-189.
37. TM technical guide and software manual. New York: Multi-Health Systems Inc; 2000.
38. McGee RA, Clark SE, Symons DK. Does the Conners' continuous performance test aid in ADHD diagnosis? J Abnorm Child Psychol 2000; 28: 415-424.
39. Edwards MC, Gardner ES, Chelonis JJ, et al. Estimates of the validity and utility of the Conners' Continuous Performance Test in the assessment of inattentive and/or hyperactive-impulsive behaviors in children. J Abnorm Child Psychol 2007; 35: 393-404.
40. Epstein JN, Conners CK, Sitarenios G, et al. Continuous Performance Test results of adults with attention deficit hyperactivity disorder. Clin Neuropsychol 1998; 12: 155-168.
41. Conners CK. Conners manual, 3rd edition. Toronto, Ontario, Canada: Multi-Health Systems Inc; 2008.
42. Barkley RA. Attention-deficit hyperactivity disorder, 3rd edition. A handbook for diagnosis and treatment. New York: Guilford Press; 2006.
43. Anderson V, Anderson D, Anderson P. Comparing attentional skills in children with acquired and developmental central nervous system disorders. J Int Neuropsychol Soc 2006; 12: 519-531.
44. Agay N, Yechiam E, Carmel Z, et al. Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology (Berl) 2010; 210: 511-519.
45. Klorman R, Bauer LO, Coons HW, et al. Enhancing effects of methylphenidate on normal young adults' cognitive processes. Psychopharmacol Bull 1984; 20: 3-9.
46. Peloquin LJ, Klorman R. Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance. J Abnorm Psychol 1986; 95: 88-98.
47. Kavale K. The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis. J Learn Disabil 1982; 15: 280-289.
48. Merchant TE, Kiehna EN, Miles MA, et al. Acute effects of irradiation on cognition: Changes in attention on a computerized continuous performance test during radiotherapy in pediatric patients with localized primary brain tumors. Int J Radiat Oncol Biol Phys 2002; 53: 1271-1278.
49. Reeves CB, Palmer S, Gross AM, et al. Brief report: Sluggish cognitive tempo among pediatric survivors of acute lymphoblastic leukemia. J Pediatr Psychol 2007; 32: 1050-1054.
50. Lahey BB, Pelham WE, Schaughency EA, et al. Dimensions and types of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1988; 27: 330-335.
51. Achenbach TM. Manual for the child behavior checklist/4-18 and 1991 profile. Burlington: University of Vermont, Department of Psychiatry; 1991.
52. Hartman CA, Willcutt EG, Rhee SH, et al. The relation between sluggish cognitive tempo and DSM-IV ADHD. J Abnorm Child Psychol 2004; 32: 491-503.
53. Carlson CL, Mann M. Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type. J Clin Child Adolesc Psychol 2002; 31: 123-129.